pe anti ulbp4 (R&D Systems)
93
Structured Review
R&D Systems
pe anti ulbp4
Pe Anti Ulbp4, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fab6285p/Human+ULBP-4%2FRAET1E+PE-conjugated+Antibody/pmc11706306-119-107-109
Average 93 stars, based on 3 article reviews
Pe Anti Ulbp4, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fab6285p/Human+ULBP-4%2FRAET1E+PE-conjugated+Antibody/pmc11706306-119-107-109
Average 93 stars, based on 3 article reviews
pe anti ulbp4 - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Virus:Article Title: Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses. Article Snippet: In brief SARS-CoV-2 uses ORF6, a conserved protein among sarbecoviruses, to evade cytotoxic cell NKG2D recognition through a mechanism that results in the shedding of the surface proteins MIC-A/B.. Inhibition of this shedding process with a monoclonal antibody enhances natural killer cell activity against the virus and offers a potential therapeutic agent to augment cytotoxic immunity against the broader family of viruses. Variant Assay:Article Title: Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses. Article Snippet: In brief SARS-CoV-2 uses ORF6, a conserved protein among sarbecoviruses, to evade cytotoxic cell NKG2D recognition through a mechanism that results in the shedding of the surface proteins MIC-A/B.. Inhibition of this shedding process with a monoclonal antibody enhances natural killer cell activity against the virus and offers a potential therapeutic agent to augment cytotoxic immunity against the broader family of viruses. Recombinant:Article Title: Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses. Article Snippet: In brief SARS-CoV-2 uses ORF6, a conserved protein among sarbecoviruses, to evade cytotoxic cell NKG2D recognition through a mechanism that results in the shedding of the surface proteins MIC-A/B.. Inhibition of this shedding process with a monoclonal antibody enhances natural killer cell activity against the virus and offers a potential therapeutic agent to augment cytotoxic immunity against the broader family of viruses. Modification:Article Title: Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses. Article Snippet: In brief SARS-CoV-2 uses ORF6, a conserved protein among sarbecoviruses, to evade cytotoxic cell NKG2D recognition through a mechanism that results in the shedding of the surface proteins MIC-A/B.. Inhibition of this shedding process with a monoclonal antibody enhances natural killer cell activity against the virus and offers a potential therapeutic agent to augment cytotoxic immunity against the broader family of viruses. |